Abstract
As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.
| Translated title of the contribution | Electrocardiographic changes: Expression of cardiotoxicity |
|---|---|
| Original language | Italian |
| Pages (from-to) | 55-59 |
| Number of pages | 5 |
| Journal | Journal of Cardiovascular Echography |
| Volume | 21 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2011 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
Fingerprint Dive into the research topics of 'Electrocardiographic changes: Expression of cardiotoxicity'. Together they form a unique fingerprint.
Cite this
Lombari, M. C., Tocchetti, C. G., Coppola, C., Boccia, A. S., & Maurea, N. (2011). Le alterazioni elettrocardiografiche espressione di cardiotossicità. Journal of Cardiovascular Echography, 21(2), 55-59. https://doi.org/10.1016/j.jcecho.2011.04.002